-
Elevating the Patient Perspective: Quantifying First-Line Preferences in Locally Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Using the Threshold Technique
Sep 9, 2025, 16:22 PM -
Real-World Evidence on Treatment Patterns and Guidelines in Patients With Advanced Merkel Cell Carcinoma Across the US and Europe
Sep 9, 2025, 16:22 PM -
The EB Insights Study: The Impact of Epidermolysis Bullosa on Carer Health-Related Quality of Life
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial
Sep 9, 2025, 16:22 PM -
EU HTA JCA PICO Consolidation Process Examples: Key Trends and Remaining Uncertainties
Sep 9, 2025, 16:22 PM -
Literature Review on the Economic Impact of Maternal Fetal Infections
Sep 9, 2025, 16:22 PM -
Model Structure Variability in NICE HTAs: Evidence From Asthma and TMA Appraisals to Support the Need for Disease-Specific Reference Models
Sep 9, 2025, 16:22 PM -
Cost Utility Analysis of a Digital Peer Navigation Program for Men With Prostate Cancer
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis NMA of Clinical Effectiveness of Second-Line (2L+) Treatments in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
Navigating Uncharted Waters: Challenge of Anticipating Technologies Subject to Environmental Considerations in Future HTA
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Dimethyl Fumarate for the Treatment of Relapsing/Remitting Multiple Sclerosis in Iraq
Sep 9, 2025, 16:22 PM -
Resource Utilization Among Patients With Epidermolysis Bullosa: Preliminary Findings From Seven European Countries
Sep 9, 2025, 16:22 PM -
What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024
Sep 9, 2025, 16:22 PM -
Ai-Augmented Data Extraction in Literature Reviews: Toward First-Pass Accuracy Competitive With Human Performance
Sep 9, 2025, 16:22 PM -
Incorporating Environmental Impact Into Health Economic Evaluations: A Review of Methodological Approaches and Practical Applications
Sep 9, 2025, 16:22 PM -
Navigating Three Systems: A Comparative Analysis of Pharmaceutical Reimbursement in Germany, Austria, and Switzerland
Sep 9, 2025, 16:22 PM -
Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Burden of Bloodstream Infections in the United States: Incidence and Healthcare Resource Utilization 2022-2024
Sep 9, 2025, 16:22 PM -
English Translation, Cross-Cultural Adaptation and Validation of the French New Patient-Reported Outcome Measures of the Multiple Sclerosis Autonomy Scale (MSAS)
Sep 9, 2025, 16:22 PM -
The Effect of Pharmaceutical Pricing Policies on Healthcare Expenditures in Turkey: Analysis for the Period 2015-2024
Sep 9, 2025, 16:22 PM
